Supernus Pharmaceuticals (SUPN) Q2 2024 Earnings

May 8Confirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-0.29
-0.01
0.28
0.56

Details

Expected EPS
0.2625
Actual EPS
0
Surprise EPS
-0.26
Surprise Percent
-100%

Description

⁨Supernus Pharmaceuticals⁩ (⁦SUPN⁩) has reported earnings of ⁦0⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts